Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population

Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected...

Full description

Saved in:
Bibliographic Details
Published inBMC cancer Vol. 22; no. 1; pp. 961 - 10
Main Authors Kong, Yunxin, Zhuo, Lin, Dong, Dong, Zhuo, Lang, Lou, Peian, Cai, Ting, Chen, Siting, Pan, Jianqiang, Gao, Yihuan, Lu, Hang, Ma, Yue, Dong, Zongmei, Luo, Xiaohu, Zhao, Hongying
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 07.09.2022
BioMed Central
BMC
Subjects
Age
Asia - epidemiology
Asymptomatic
Body mass index
Cancer
Cancer screening
China - epidemiology
Colonoscopy
Colorectal cancer
Colorectal carcinoma
Colorectal neoplasia
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - prevention & control
Cross-Sectional Studies
Diabetes
Diagnosis
Early detection of cancer
Family medical history
Humans
Mass screening
Medical screening
Population
Questionnaires
Reclassification
Risk assessment
Risk factors
Risk groups
Statistical analysis
Tumors
Urban areas
Validation studies as topic
Asia
China
Validation studies as topic
Early detection of cancer
Colorectal neoplasia
Mass screening
Risk assessment
Online AccessGet full text

Cover

Abstract Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50-3.22) [8-point risk] to 4.00 (2.41-6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53-0.62) [8-point risk] to 0.65 (0.61-0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83-40.70) [8-point risk] to 84.82 (76.81-90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12-45.90) [Modified APCS] to 83.81 (81.96-85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from - 10.34% (95%C.I.: - 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: - 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1-3] [8-point risk] to 11 [3-5] [APCS and Modified APCS]. The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
AbstractList Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50-3.22) [8-point risk] to 4.00 (2.41-6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53-0.62) [8-point risk] to 0.65 (0.61-0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83-40.70) [8-point risk] to 84.82 (76.81-90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12-45.90) [Modified APCS] to 83.81 (81.96-85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from - 10.34% (95%C.I.: - 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: - 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1-3] [8-point risk] to 11 [3-5] [APCS and Modified APCS]. The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
Background Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. Methods We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). Results 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50-3.22) [8-point risk] to 4.00 (2.41-6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53-0.62) [8-point risk] to 0.65 (0.61-0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83-40.70) [8-point risk] to 84.82 (76.81-90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12-45.90) [Modified APCS] to 83.81 (81.96-85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from - 10.34% (95%C.I.: - 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: - 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1-3] [8-point risk] to 11 [3-5] [APCS and Modified APCS]. Conclusions The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system. Keywords: Colorectal neoplasia, Mass screening, Early detection of cancer, Risk assessment, Validation studies as topic
Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score.BACKGROUNDColorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score.We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN).METHODSWe conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN).1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50-3.22) [8-point risk] to 4.00 (2.41-6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53-0.62) [8-point risk] to 0.65 (0.61-0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83-40.70) [8-point risk] to 84.82 (76.81-90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12-45.90) [Modified APCS] to 83.81 (81.96-85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from - 10.34% (95%C.I.: - 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: - 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1-3] [8-point risk] to 11 [3-5] [APCS and Modified APCS].RESULTS1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50-3.22) [8-point risk] to 4.00 (2.41-6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53-0.62) [8-point risk] to 0.65 (0.61-0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83-40.70) [8-point risk] to 84.82 (76.81-90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12-45.90) [Modified APCS] to 83.81 (81.96-85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from - 10.34% (95%C.I.: - 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: - 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1-3] [8-point risk] to 11 [3-5] [APCS and Modified APCS].The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.CONCLUSIONSThe APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
Abstract Background Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. Methods We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). Results 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50–3.22) [8-point risk] to 4.00 (2.41–6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53–0.62) [8-point risk] to 0.65 (0.61–0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83–40.70) [8-point risk] to 84.82 (76.81–90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12–45.90) [Modified APCS] to 83.81 (81.96–85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from − 10.34% (95%C.I.: − 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: − 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1–3] [8-point risk] to 11 [3–5] [APCS and Modified APCS]. Conclusions The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50-3.22) [8-point risk] to 4.00 (2.41-6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53-0.62) [8-point risk] to 0.65 (0.61-0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83-40.70) [8-point risk] to 84.82 (76.81-90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12-45.90) [Modified APCS] to 83.81 (81.96-85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from - 10.34% (95%C.I.: - 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: - 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1-3] [8-point risk] to 11 [3-5] [APCS and Modified APCS]. The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
Background Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its modified versions to select high-risk populations for early colonoscopy, but external validation remains rare, and which score should be selected for CRC screening in China is unclear. Validation of multiple scores in the same population might help to choose the best performing score. Methods We conducted a cross-sectional study under the framework of Cancer Screening Program in Urban China, data from asymptomatic colorectal cancer screening in Xuzhou was used to validate the APCS score, the colorectal neoplasia predict (CNP) score, the Korean colorectal screening (KCS) score, the Modified APCS score and the 8-point risk score in predicting colorectal advanced neoplasia (CAN). Results 1804 subjects were included in the analysis and 112 CAN (6.21%) was detected. In each score, the detection rate of CAN was higher in the high-risk group than in the non-high-risk group (P < 0.05), and the RR (95%C.I.) ranged 2.20 (1.50–3.22) [8-point risk] to 4.00 (2.41–6.65) [Modified APCS]. The c-statistics (95%C.I.) of the scoring systems ranged from 0.58 (0.53–0.62) [8-point risk] to 0.65 (0.61–0.69) [KCS]. The sensitivity (95%C.I.) of these systems ranged from 31.25 (22.83–40.70) [8-point risk] to 84.82 (76.81–90.90) [Modified APCS], while the specificity (95%C.I.) ranged from 43.50 (41.12–45.90) [Modified APCS] to 83.81 (81.96–85.53) [8-point risk]. Using the APCS scoring system as a comparator, the net reclassification improvement (NRI) of each modified version ranged from − 10.34% (95%C.I.: − 22.63 to 1.95%) [8-point risk] to 4.79% (95%C.I.: − 1.50% to 11.08) [KCS]. The colonoscopy resource load (95%C.I.) ranged from 9 [1–3] [8-point risk] to 11 [3–5] [APCS and Modified APCS]. Conclusions The APCS score and its modified versions have certain ability to predict the risk of advanced neoplasia and reduce the resource load. The modified APCS score and the KCS score seemed the preferable systems to classify high risk subjects based on its high RR, sensitivity and predictive ability in the selected population. Future research could focus on adding risk factors or combining with laboratory test results to improve the predictive power of the scoring system.
ArticleNumber 961
Audience Academic
Author Ma, Yue
Pan, Jianqiang
Zhao, Hongying
Lu, Hang
Cai, Ting
Chen, Siting
Dong, Zongmei
Zhuo, Lang
Gao, Yihuan
Dong, Dong
Kong, Yunxin
Luo, Xiaohu
Lou, Peian
Zhuo, Lin
Author_xml – sequence: 1
  givenname: Yunxin
  surname: Kong
  fullname: Kong, Yunxin
– sequence: 2
  givenname: Lin
  surname: Zhuo
  fullname: Zhuo, Lin
– sequence: 3
  givenname: Dong
  surname: Dong
  fullname: Dong, Dong
– sequence: 4
  givenname: Lang
  surname: Zhuo
  fullname: Zhuo, Lang
– sequence: 5
  givenname: Peian
  surname: Lou
  fullname: Lou, Peian
– sequence: 6
  givenname: Ting
  surname: Cai
  fullname: Cai, Ting
– sequence: 7
  givenname: Siting
  surname: Chen
  fullname: Chen, Siting
– sequence: 8
  givenname: Jianqiang
  surname: Pan
  fullname: Pan, Jianqiang
– sequence: 9
  givenname: Yihuan
  surname: Gao
  fullname: Gao, Yihuan
– sequence: 10
  givenname: Hang
  surname: Lu
  fullname: Lu, Hang
– sequence: 11
  givenname: Yue
  surname: Ma
  fullname: Ma, Yue
– sequence: 12
  givenname: Zongmei
  surname: Dong
  fullname: Dong, Zongmei
– sequence: 13
  givenname: Xiaohu
  surname: Luo
  fullname: Luo, Xiaohu
– sequence: 14
  givenname: Hongying
  surname: Zhao
  fullname: Zhao, Hongying
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36071414$$D View this record in MEDLINE/PubMed
BookMark eNp9k1uL1DAUx4usuBf9Aj5IQRB96Jpbm_ZFGAYvCwuKt9eQJqczWTLJmKSL-0H8vqYz6zpdRPKQcPL7_5OcnHNaHDnvoCieYnSOcdu8jpi0bV0hQiqMEOPVzYPiBDOOK8IQPzpYHxenMV4hhHmL2kfFMW0Qxwyzk-LXd2mNlsl4V_qhTGsoF9HI6pNUZjCqVN76ACpJW0YVAJxxq7zKsVI6XZoUy43XGQVdXkOI2SeWxpXbANqoNNEHFlJfS6cy6sBvrcwHTexybRxEKLd-O9rdVR4XDwdpIzy5nc-Kb-_efl1-qC4_vr9YLi4r1ZA2VapGAwGkCMF1zZtOdpiDBkp7PLBB1bXiqOWKsh6GGhDhWOI-83VPaaOpomfFxd5Xe3kltsFsZLgRXhqxC_iwEjIkoywIgonStJda856hgfdENg1toJUcWEea7PVm77Ud-w1oBS4FaWem8x1n1mLlr0XHakQpywYvbw2C_zFCTGJjogJrZc7WGEW-Pm4ZYZhm9Pk99MqPweVUTVTNurrj5C-1kvkBxg0-n6smU7HguKkJwt1Enf-DykPDxqhccYPJ8Zng1UyQmQQ_00qOMYqLL5_n7IsDdg3SpnX0dpw-Oc7BZ4fZu0vbn0rNANkDKvgYAwx3CEZiagexbweR20Hs2kHcZFF7T6RM2lVYfqOx_5P-BpJiDxA
CitedBy_id crossref_primary_10_1111_jgh_16523
Cites_doi 10.3389/fmed.2021.800566
10.1136/bmjopen-2018-025935
10.6004/jnccn.2020.0048
10.3390/cancers12061408
10.1016/j.gie.2019.02.023
10.1097/MCG.0000000000000102
10.1186/s12916-014-0241-z
10.1093/nutrit/nuz024
10.1016/j.jncc.2022.02.002
10.1159/000501073
10.1053/j.gastro.2017.05.013
10.1002/ijc.31198
10.1002/ijc.32377
10.1001/jamaoncol.2020.7338
10.1136/gutjnl-2018-317124
10.1136/gutjnl-2013-305639
10.14309/ajg.0000000000000624
10.1038/s41395-018-0209-2
10.1136/gut.2010.221168
10.14309/ctg.0000000000000319
10.1016/S0140-6736(19)32319-0
10.1111/jgh.13835
10.3748/wjg.v20.i32.11394
10.1093/aje/kwx376
10.3322/caac.21660
10.1007/s00535-018-1433-7
10.1056/NEJMsr1714643
10.1007/s00125-017-4229-z
10.14309/ajg.0000000000001122
10.1093/jn/nxz268
10.7326/M19-0699
10.1016/j.annonc.2020.02.012
10.1136/gutjnl-2013-306503
ContentType Journal Article
Copyright 2022. The Author(s).
COPYRIGHT 2022 BioMed Central Ltd.
2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
The Author(s) 2022
Copyright_xml – notice: 2022. The Author(s).
– notice: COPYRIGHT 2022 BioMed Central Ltd.
– notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: The Author(s) 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12885-022-10047-y
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList



MEDLINE - Academic

MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ: Directory of Open Access Journal (DOAJ)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2407
EndPage 10
ExternalDocumentID oai_doaj_org_article_212cd3badd7b40f7b2a6636e8a7e4926
PMC9450334
A716520192
36071414
10_1186_s12885_022_10047_y
Genre Journal Article
GeographicLocations Asia
China
GeographicLocations_xml – name: China
– name: Asia
GrantInformation_xml – fundername: CAMS Innovation Fund for Medical Sciences
  grantid: 2017-I2M-1-006
– fundername: ;
– fundername: ;
  grantid: 2017-I2M-1-006; 2017-I2M-1-006; 2017-I2M-1-006; 2017-I2M-1-006; 2017-I2M-1-006; 2017-I2M-1-006; 2017-I2M-1-006
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACMJI
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
ISR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
-A0
3V.
ACRMQ
ADINQ
C24
CGR
CUY
CVF
ECM
EIF
NPM
PMFND
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c628t-c50f2e0c22155769a917ede33b1f4fc55c7087c34bef5e0271a1be0c5b336d3c3
IEDL.DBID M48
ISSN 1471-2407
IngestDate Wed Aug 27 01:32:12 EDT 2025
Thu Aug 21 18:26:31 EDT 2025
Fri Jul 11 08:22:30 EDT 2025
Fri Jul 25 03:45:06 EDT 2025
Tue Jun 17 21:30:26 EDT 2025
Tue Jun 10 20:09:45 EDT 2025
Fri Jun 27 04:25:38 EDT 2025
Thu May 22 21:23:35 EDT 2025
Thu Jan 02 22:30:26 EST 2025
Thu Apr 24 22:57:45 EDT 2025
Tue Jul 01 04:29:20 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Validation studies as topic
Early detection of cancer
Colorectal neoplasia
Mass screening
Risk assessment
Language English
License 2022. The Author(s).
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c628t-c50f2e0c22155769a917ede33b1f4fc55c7087c34bef5e0271a1be0c5b336d3c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-022-10047-y
PMID 36071414
PQID 2715495972
PQPubID 44074
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_212cd3badd7b40f7b2a6636e8a7e4926
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9450334
proquest_miscellaneous_2711842413
proquest_journals_2715495972
gale_infotracmisc_A716520192
gale_infotracacademiconefile_A716520192
gale_incontextgauss_ISR_A716520192
gale_healthsolutions_A716520192
pubmed_primary_36071414
crossref_primary_10_1186_s12885_022_10047_y
crossref_citationtrail_10_1186_s12885_022_10047_y
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-09-07
PublicationDateYYYYMMDD 2022-09-07
PublicationDate_xml – month: 09
  year: 2022
  text: 2022-09-07
  day: 07
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC cancer
PublicationTitleAlternate BMC Cancer
PublicationYear 2022
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References A Shaukat (10047_CR18) 2021; 116
H Sung (10047_CR1) 2021; 71
M Sekiguchi (10047_CR11) 2018; 53
S Shaw (10047_CR22) 2021; 8
S McNabb (10047_CR28) 2020; 146
R Zheng (10047_CR2) 2022; 2
H Chen (10047_CR19) 2019; 9
10047_CR23
DH Kim (10047_CR10) 2015; 49
K Hidayat (10047_CR32) 2020; 78
JJY Sung (10047_CR6) 2015; 64
JJY Sung (10047_CR9) 2018; 33
L Schwingshackl (10047_CR31) 2018; 142
W Jiang (10047_CR15) 2020; 101
D Provenzale (10047_CR17) 2020; 18
C Bosetti (10047_CR29) 2020; 31
GS Collins (10047_CR13) 2015; 13
K Yeoh (10047_CR7) 2011; 60
L Peng (10047_CR12) 2018; 113
H Chen (10047_CR20) 2020; 115
XF Pan (10047_CR25) 2018; 187
MCS Wong (10047_CR8) 2014; 63
P Ye (10047_CR21) 2020; 12
S Bopanna (10047_CR26) 2017; 2
DK Rex (10047_CR16) 2017; 153
10047_CR3
Y Chen (10047_CR24) 2017; 60
CH Park (10047_CR34) 2019; 86
MA Han (10047_CR27) 2019; 171
M Sekiguchi (10047_CR33) 2021; 12
B Lauby-Secretan (10047_CR4) 2018; 378
J Wang (10047_CR14) 2014; 20
C Guo (10047_CR30) 2021; 7
H Chen (10047_CR5) 2019; 68
References_xml – volume: 8
  start-page: 800566
  year: 2021
  ident: 10047_CR22
  publication-title: Front Med
  doi: 10.3389/fmed.2021.800566
– volume: 9
  start-page: e025935
  year: 2019
  ident: 10047_CR19
  publication-title: BMJ Open
  doi: 10.1136/bmjopen-2018-025935
– volume: 18
  start-page: 1312
  year: 2020
  ident: 10047_CR17
  publication-title: J Natl Compr Cancer Netw
  doi: 10.6004/jnccn.2020.0048
– volume: 12
  start-page: 1408
  year: 2020
  ident: 10047_CR21
  publication-title: Cancers
  doi: 10.3390/cancers12061408
– volume: 86
  start-page: 1204
  year: 2019
  ident: 10047_CR34
  publication-title: Gastrointest Endosc
  doi: 10.1016/j.gie.2019.02.023
– volume: 49
  start-page: 41
  year: 2015
  ident: 10047_CR10
  publication-title: J Clin Gastroenterol
  doi: 10.1097/MCG.0000000000000102
– volume: 13
  start-page: 1
  year: 2015
  ident: 10047_CR13
  publication-title: BMC Med
  doi: 10.1186/s12916-014-0241-z
– volume: 78
  start-page: 1
  year: 2020
  ident: 10047_CR32
  publication-title: Nutr Rev
  doi: 10.1093/nutrit/nuz024
– volume: 2
  start-page: 1
  year: 2022
  ident: 10047_CR2
  publication-title: J Natl Cancer Center
  doi: 10.1016/j.jncc.2022.02.002
– volume: 101
  start-page: 484
  year: 2020
  ident: 10047_CR15
  publication-title: Digestion
  doi: 10.1159/000501073
– volume: 153
  start-page: 307
  year: 2017
  ident: 10047_CR16
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2017.05.013
– volume: 2
  start-page: 269
  year: 2017
  ident: 10047_CR26
  publication-title: Lancet
– volume: 142
  start-page: 1748
  year: 2018
  ident: 10047_CR31
  publication-title: Int J Cancer
  doi: 10.1002/ijc.31198
– volume: 146
  start-page: 861
  year: 2020
  ident: 10047_CR28
  publication-title: Int J Cancer
  doi: 10.1002/ijc.32377
– volume: 7
  start-page: 428
  year: 2021
  ident: 10047_CR30
  publication-title: JAMA Oncol
  doi: 10.1001/jamaoncol.2020.7338
– volume: 68
  start-page: 1450
  year: 2019
  ident: 10047_CR5
  publication-title: Gut
  doi: 10.1136/gutjnl-2018-317124
– volume: 63
  start-page: 1130
  year: 2014
  ident: 10047_CR8
  publication-title: Gut
  doi: 10.1136/gutjnl-2013-305639
– volume: 115
  start-page: 1264
  year: 2020
  ident: 10047_CR20
  publication-title: Am J Gastroenterol
  doi: 10.14309/ajg.0000000000000624
– volume: 113
  start-page: 1788
  year: 2018
  ident: 10047_CR12
  publication-title: Am J Gastroenterol
  doi: 10.1038/s41395-018-0209-2
– volume: 60
  start-page: 1236
  year: 2011
  ident: 10047_CR7
  publication-title: Gut
  doi: 10.1136/gut.2010.221168
– volume: 12
  start-page: e00319
  year: 2021
  ident: 10047_CR33
  publication-title: Clin Transl Gastroenterol
  doi: 10.14309/ctg.0000000000000319
– ident: 10047_CR3
  doi: 10.1016/S0140-6736(19)32319-0
– volume: 33
  start-page: 187
  year: 2018
  ident: 10047_CR9
  publication-title: J Gastroenterol Hepatol
  doi: 10.1111/jgh.13835
– volume: 20
  start-page: 11394
  year: 2014
  ident: 10047_CR14
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v20.i32.11394
– volume: 187
  start-page: 1380
  year: 2018
  ident: 10047_CR25
  publication-title: Am J Epidemiol
  doi: 10.1093/aje/kwx376
– volume: 71
  start-page: 209
  year: 2021
  ident: 10047_CR1
  publication-title: CA Cancer J Clin
  doi: 10.3322/caac.21660
– volume: 53
  start-page: 1109
  year: 2018
  ident: 10047_CR11
  publication-title: J Gastroenterol
  doi: 10.1007/s00535-018-1433-7
– volume: 378
  start-page: 1734
  year: 2018
  ident: 10047_CR4
  publication-title: N Engl J Med
  doi: 10.1056/NEJMsr1714643
– volume: 60
  start-page: 1022
  year: 2017
  ident: 10047_CR24
  publication-title: Diabetologia
  doi: 10.1007/s00125-017-4229-z
– volume: 116
  start-page: 458
  year: 2021
  ident: 10047_CR18
  publication-title: Am J Gastroenterol
  doi: 10.14309/ajg.0000000000001122
– ident: 10047_CR23
  doi: 10.1093/jn/nxz268
– volume: 171
  start-page: 711
  year: 2019
  ident: 10047_CR27
  publication-title: Ann Intern Med
  doi: 10.7326/M19-0699
– volume: 31
  start-page: 558
  year: 2020
  ident: 10047_CR29
  publication-title: Ann Oncol
  doi: 10.1016/j.annonc.2020.02.012
– volume: 64
  start-page: 121
  year: 2015
  ident: 10047_CR6
  publication-title: Gut
  doi: 10.1136/gutjnl-2013-306503
SSID ssj0017808
Score 2.3893518
Snippet Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score and its...
Background Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening (APCS) score...
Abstract Background Colorectal cancer is one of the most common cancers in the world. Several studies suggest using the Asia-Pacific colorectal screening...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 961
SubjectTerms Age
Asia - epidemiology
Asymptomatic
Body mass index
Cancer
Cancer screening
China - epidemiology
Colonoscopy
Colorectal cancer
Colorectal carcinoma
Colorectal neoplasia
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - prevention & control
Cross-Sectional Studies
Diabetes
Diagnosis
Early detection of cancer
Family medical history
Humans
Mass screening
Medical screening
Population
Questionnaires
Reclassification
Risk assessment
Risk factors
Risk groups
Statistical analysis
Tumors
Urban areas
Validation studies as topic
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgvIKtMUgJA7IamI7cXJcKqqCVA5AUW-W7dh0Jciuml2k_hD-LzOOE22EBBduq_hLNmuP57Ez_oaQV4pbZ8AdYlVoA5OVE6xpfMEcOHINL72wsRjz_GN1diE_XJaXO62-sCZsoAceJu4YVKtrhYVtqKzMg7LcgJGsfG2UR7I71L5g88ZgKuUPVJ3X4xGZujruQQvXeBKZM2RIU-xmZoYiW_-fOnnHKM0LJncs0Ok9cje5jnQxvPJ9cst3--T2eUqOPyC_voJPPbRIoqtAwbOji35pWKq7o8hPjfoNngG6AuJXsFrwCa5R07V0uenpj1ULUN_Sn8PfaD1ddnR9jV-B5dG7jxiLB2iHNeh4FhOx2I7b956up75gD8nF6bsvJ2csdV1gruL1hrkyD9znjoMzAMFIYyCg860XwhZBBleWTuW1ckJaH0oPUW1hCgv40gpRtcKJR2SvW3X-CaGhldKBS-cLB25OYzBpy7k1tuBF2zifkWJcBO0SJTl2xviuY2hSV3pYOA136bhw-iYjb6Z71gMhx1_Rb3FtJySSaccLIGI6iZj-l4hl5DlKhh5Opk4qQS8g1iw5-sgZeRkRSKjRYcXON7Pte_3-86cZ6HUChRX8SmfSAQiYK-TgmiEPZkjY8W4-PIqoThqn17AOEOpDeAjDL6ZhvBOr6EAUthEDAT1mUjPyeJDoaWYEEg3KQmZEzWR9NnXzkW55FfnIG4m5cPn0f8z1M3KH4zbFlJ06IHub660_BLdvY4_iDv8Ne0ZWfg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96gvgifls9NYrgg4RrPtq0T7KKxymcD-rJvoUkTc8FbdftrnB_iP-vM21atwj3tjST7m4ymfwmM_kNIS-1cN4CHGJ5XdVM5V6ysgyceQBypciCdH0y5umn_ORMfVxmy3jg1sW0ytEm9oa6aj2ekR8JjWRiAH_Fm_UvhlWjMLoaS2hcJdeQugy1Wi8nh4vrIi3GizJFftSBLS7wPrJgyJOm2cVsM-o5-_-3zHtb0zxtcm8fOr5FbkYASRfDjN8mV0Jzh1w_jSHyu-TPN0DWQ6Ek2tYU8B1ddCvLYvYdRZZqtHLwDrAY4MXC3gWf4Bm1TUVX247-bCsQDRX9PRymdXTV0PUGvwKTpPdfMaYQ0AYz0fFGJspiUe7QBbqeqoPdI2fH77--O2Gx9gLzuSi2zGdpLULqBUACcElKC25dqIKUjteq9lnmdVpoL5ULdRbAt-WWO5DPnJR5Jb28Tw6atgkPCa0rpTwAu8A9gJ3SYuhWCGcdF7wqfUgIHyfB-EhMjvUxfpjeQSlyM0ycgV6mnzhzkZDXU5_1QMtxqfRbnNtJEim1-wft5tzEFWpgD_eVdGDvtVNprZ2wgMbyUFgdkFUxIc9QM8xwP3UyDGYBHmcmECkn5EUvgbQaDebtnNtd15kPXz7PhF5FobqFf-ltvAYBY4VMXDPJw5kkrHs_bx5V1ES705l_qyQhz6dm7Im5dKAKu14G3HqMpybkwaDR08hIpBtUXCVEz3R9NnTzlmb1vWclLxVGxNWjy3_WY3JD4ALEkJw-JAfbzS48AVi3dU_7tfsXP3xNpg
  priority: 102
  providerName: ProQuest
Title Validation of the Asia-Pacific colorectal screening score and its modified versions in predicting colorectal advanced neoplasia in Chinese population
URI https://www.ncbi.nlm.nih.gov/pubmed/36071414
https://www.proquest.com/docview/2715495972
https://www.proquest.com/docview/2711842413
https://pubmed.ncbi.nlm.nih.gov/PMC9450334
https://doaj.org/article/212cd3badd7b40f7b2a6636e8a7e4926
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELf2IU17QXyTMYpBSDygsMZ24uQBoRZtGkidUKGo4sWKHWdUGmnXtIj-Ify_3DkfNGLigZcois-pat_H73LnO0JeSKZNCnDIj_Is90VkuJ8kNvANALmEhZZrl4w5uojOJ-LDNJzukKbdUb2A5Y2uHfaTmiyvXv-83rwFgX_jBD6OTkrQsTGeM2Y-1j-T_maX7INlktjRYCT-RBVk3I-bgzM3zjskBxwLrolAdOyUK-f_t9LeslrdjMotE3V2m9yqsSUdVMxwh-zY4i45GNXR83vk1xcA3VUPJTrPKUA_OihnqV8n5lEsYI0KEN4BygQcXDBrcAfPaFpkdLYq6fd5BqQ2oz-q72wlnRV0scSfwPzp7Vc02QW0wCR1PKyJtNiv25aWLtrGYffJ5Oz087tzv27L4JuIxSvfhP2c2b5hgBbAW0lS8PhsZjnXQS5yE4ZG9mNpuNA2Dy24vUEaaKAPNedRxg1_QPaKeWEfEZpnQhjAfDYwgIOSFKO6jOlUByzIEmM9EjSboExdsxxbZ1wp57vEkar2UMEs5fZQbTzyqp2zqCp2_JN6iHvbUmK1bfdgvrxUtfAqMO8m4xpMgdSin0vNUgBqkY1TabHgokeeImeo6uhqqzPUAJzRkCGI9shzR4EVNwpM6blM12Wp3n8ad4he1kT5HP6lSesTErBWWKSrQ3ncoQSVYLrDDYuqRqIU7EMI3nAiYfhZO4wzMc0OWGHtaMDjx1CrRx5WHN2uTCMYHpEdXu8sXXekmH1zBcsTgcFycfTfMx-TQ4ZiioE8eUz2Vsu1fQJgcKV7ZFdOZY_sD08vPo577pNKz0k9XMfDr78B_uhizA
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lj9MwELaWRQIuiDeBhTUIxAFFGztOnBwQKo_Vlt3uAXZRb8Z2nKUSJKVpQf0h_A1-IzN50Qhpb3ur4rHbesYz38TzIOSZ5MZqgEN-nGe5L2Ib-mnqmG8ByKU8cqGpgzEnx_HBqfgwjaZb5E-XC4NhlZ1OrBV1Vlp8R77HJRYTA_jLX89_-Ng1Cm9XuxYajVgcuvUvcNmqV-N3wN_nnO-_P3l74LddBXwb82Tp2yjIuQssB2MHYDvV4LC4zIWhYbnIbRRZGSTShsK4PHLgtTHNDNBHJgzjLLQhrHuJXAbDG6CzJ6e9g8dkEiRdYk4S71Wg-xPMf-Y-1mWT_npg_OoeAf9bgg1TOAzT3LB7-zfI9Raw0lEjYTfJlitukSuT9kr-Nvn9GZB805iJljkFPElH1Uz7bbQfxarYqFVhDdBQ4DWDrYRP8IzqIqOzZUW_lxmQuoz-bF7eVXRW0PkCvwKDsjeX6EIWaIGR75gBirTYBNxVjs77bmR3yOmFcOUu2S7Kwt0nNM-EsAAkHbMArlKNV8WcG20YZ1lqnUdYxwRl20Lo2I_jm6odoiRWDeMUzFI149TaIy_7OfOmDMi51G-Qtz0llvCuH5SLM9VqBAWYwWahAfsijQhyabgG9Be7REuHVRw9souSoZp82F4RqRF4uBFHZO6RpzUFlvEoME7oTK-qSo0_fRwQvWiJ8hL-pdVt2gXsFVb-GlDuDChBz9jhcCeiqtVzlfp3Kj3ypB_GmRi7B6KwqmlYIvD-1iP3GonudybE8oaCCY_IgawPtm44Usy-1lXQU4E38OLB-T9rl1w9OJkcqaPx8eFDco3jYcTrQLlDtpeLlXsEkHJpHtfnmJIvF604_gJDBYqD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+the+Asia-Pacific+colorectal+screening+score+and+its+modified+versions+in+predicting+colorectal+advanced+neoplasia+in+Chinese+population&rft.jtitle=BMC+cancer&rft.au=Kong%2C+Yunxin&rft.au=Zhuo%2C+Lin&rft.au=Dong%2C+Dong&rft.au=Zhuo%2C+Lang&rft.date=2022-09-07&rft.pub=BioMed+Central&rft.eissn=1471-2407&rft.volume=22&rft_id=info:doi/10.1186%2Fs12885-022-10047-y&rft_id=info%3Apmid%2F36071414&rft.externalDocID=PMC9450334
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon